Progress in Mantle-Cell Lymphoma-Reference-Cited by-同舟云学术

Progress in Mantle-Cell Lymphoma

Published:2009-02-01 Issue:4 Volume:27 Page:481-483
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Martin Peter¹,Coleman Morton¹,Leonard John P.¹

Affiliation:

1. Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology; and Department of Medicine, Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.5032

Reference40 articles.

1. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

2. Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period

3. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.

4. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study

5. Patterns of survival in mantle cell lymphoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair;Anti-Cancer Drugs;2018-10

2. Current trials for frontline therapy of mantle cell lymphoma;Journal of Hematology & Oncology;2018-01-27

3. Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status;Leukemia & Lymphoma;2016-04-13

4. Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth;CANCER BIOL MED;2015

5. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy;Clinical Cancer Research;2015-09-08